• 1. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 2. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220
• 3. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 4. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 5. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridines and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives

Introduction to (5-Fluoropyridin-3-yl)methanol (CAS No: 22620-32-2)

(5-Fluoropyridin-3-yl)methanol, with the chemical formula C?H?FN?O, is a fluorinated pyridine derivative that has garnered significant attention in the field of pharmaceutical and chemical research. This compound, identified by its CAS number 22620-32-2, is a versatile intermediate in the synthesis of various bioactive molecules. Its unique structural features, particularly the presence of a fluorine atom and a hydroxymethyl group, make it a valuable building block for the development of novel therapeutic agents.

The fluoropyridine scaffold is widely recognized for its role in medicinal chemistry due to its ability to enhance metabolic stability, binding affinity, and pharmacokinetic properties of drug candidates. The introduction of a fluorine atom at the 5-position of the pyridine ring further modulates these properties, making (5-fluoropyridin-3-yl)methanol a particularly interesting compound for drug discovery. Recent studies have highlighted its potential in the development of small-molecule inhibitors targeting various biological pathways.

In particular, research has demonstrated that (5-fluoropyridin-3-yl)methanol can serve as a key intermediate in the synthesis of kinase inhibitors. Kinases are enzymes that play crucial roles in cell signaling and are often implicated in diseases such as cancer and inflammatory disorders. By modifying the structure of kinase inhibitors with fluorinated pyridine moieties, researchers aim to improve their selectivity and efficacy. For instance, studies have shown that compounds derived from (5-fluoropyridin-3-yl)methanol exhibit promising activity against tyrosine kinases, which are central to many signaling cascades involved in cell growth and differentiation.

Another area where (5-fluoropyridin-3-yl)methanol has shown promise is in the development of antiviral agents. The fluoro group's ability to influence molecular interactions makes it an effective tool for designing compounds that can disrupt viral replication cycles. Recent investigations have explored its use in synthesizing inhibitors targeting viral proteases and polymerases. These inhibitors are critical for preventing viruses from replicating and spreading within host cells. The hydroxymethyl group on (5-fluoropyridin-3-yl)methanol also provides a site for further functionalization, allowing for the creation of more complex and potent antiviral molecules.

The compound's utility extends beyond its role as an intermediate in drug synthesis. It has also been investigated for its potential applications in materials science and agrochemicals. For example, fluorinated pyridines are known to enhance the stability and bioavailability of agrochemicals, making them more effective at controlling pests and diseases. Additionally, researchers are exploring its use in developing advanced materials with improved electronic properties, which could have applications in organic electronics and sensors.

The synthesis of (5-fluoropyridin-3-yl)methanol typically involves multi-step organic reactions that require careful optimization to ensure high yields and purity. Common synthetic routes include nucleophilic substitution reactions on halogenated pyridines followed by reduction or formylation steps to introduce the hydroxymethyl group. Advances in synthetic methodologies have enabled more efficient and scalable production processes, making this compound more accessible for industrial applications.

Evaluation of (5-fluoropyridin-3-yl)methanol's pharmacological properties has revealed several promising characteristics. Preclinical studies have indicated that it exhibits low toxicity profiles and good solubility in aqueous solutions, which are desirable traits for any potential therapeutic agent. Furthermore, its ability to cross cell membranes suggests it may have applications in drug delivery systems designed to target specific cellular compartments.

The growing interest in fluorinated pyridines as pharmacophores underscores the importance of compounds like (5-fluoropyridin-3-yl)methanol in modern drug discovery. As research continues to uncover new therapeutic targets and mechanisms, the demand for versatile intermediates like this one is expected to rise. Collaborative efforts between academia and industry are likely to drive further innovation, leading to the development of novel drugs that address unmet medical needs.

In conclusion, (5-fluoropyridin-3-yl)methanol (CAS No: 22620-32-2) is a multifaceted compound with significant potential in pharmaceutical research. Its unique structural features make it an invaluable intermediate for synthesizing bioactive molecules targeting various diseases. With ongoing advancements in synthetic chemistry and drug development technologies, this compound is poised to play a crucial role in the discovery and creation of next-generation therapeutics.

• 402-66-4(5-fluoropyridine-3-carboxylic acid)
• 887974-11-0((5-(3-Fluorophenyl)pyridin-3-yl)methanol)
• 1346691-78-8((5-(3,5-Difluorophenyl)pyridin-3-yl)methanol)
• 22620-33-3(3-Pyridinemethanol,5-fluoro-, hydrochloride (1:1))
• 870063-60-8((3-Fluoropyridin-4-yl)methanol)
• 35865-30-6(3-Pyridinemethanol,5-fluoro-, 1-oxide)
• 407-21-6(3-Fluoro-5-methylpyridine)
• 917835-69-9(3-Fluoro-5-(hydroxymethyl)-2-methylpyridine)
• 1227588-79-5((2,5-difluoro-3-pyridinyl)methanol)
• 222551-22-6((5-(4-Fluorophenyl)pyridin-3-yl)methanol)